Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 4:35 pm Sale | 2025-09-30 | 13G | Third Harmonic Bio, Inc. THRD | Nantahala Capital Management, LLC | 0 0.000% | -2,938,700![]() (Position Closed) | Filing History |
| 2025-11-14 4:34 pm Purchase | 2025-09-30 | 13G | 1-800-FLOWERS.COM, Inc. FLWS | Nantahala Capital Management, LLC | 3,368,065 9.210% | 1,368,065![]() (+68.40%) | Filing History |
| 2025-11-14 4:33 pm Purchase | 2025-09-30 | 13G | Savara Inc. SVRA | Nantahala Capital Management, LLC | 8,775,375 5.080% | 8,775,375![]() (New Position) | Filing History |
| 2025-11-14 4:32 pm Sale | 2025-09-30 | 13G | RAPT Therapeutics, Inc. RAPT | Nantahala Capital Management, LLC | 623,282 3.770% | -328,331![]() (-34.50%) | Filing History |
| 2025-11-14 4:32 pm Purchase | 2025-09-30 | 13G | Quince Therapeutics, Inc. QNCX | Nantahala Capital Management, LLC | 5,620,422 9.990% | 854,560![]() (+17.93%) | Filing History |
| 2025-11-14 4:31 pm Sale | 2025-09-30 | 13G | Nektar Therapeutics NKTR | Nantahala Capital Management, LLC | 418,522 2.200% | -291,239![]() (-41.03%) | Filing History |
| 2025-11-14 4:31 pm Purchase | 2025-09-30 | 13G | Kiora Pharmaceuticals, Inc. KPRX | Nantahala Capital Management, LLC | 363,712 9.990% | 57,450![]() (+18.76%) | Filing History |
| 2025-11-04 11:40 am Purchase | 2025-11-03 | 13D | Evoke Pharma, Inc. EVOK | Nantahala Capital Management, LLC | 268,431 15.990% | 268,431![]() (New Position) | Filing History |
| 2025-10-06 4:34 pm Purchase | 2025-09-30 | 13G | Abeona Therapeutics Inc. ABEO | Nantahala Capital Management, LLC | 5,184,662 9.990% | 187,561![]() (+3.75%) | Filing History |
| 2025-08-14 4:45 pm Purchase | 2025-06-30 | 13G | Nektar Therapeutics NKTR | Nantahala Capital Management, LLC | 709,761 5.720% | 709,761![]() (New Position) | Filing History |
| 2025-08-14 4:44 pm Purchase | 2025-06-30 | 13G | Immunic, Inc. IMUX | Nantahala Capital Management, LLC | 10,634,565 9.990% | 10,634,565![]() (New Position) | Filing History |
| 2025-08-14 4:44 pm Purchase | 2025-06-30 | 13G | Herbalife Nutrition Ltd. HLF | Nantahala Capital Management, LLC | 7,122,298 6.990% | 1,222,298![]() (+20.72%) | Filing History |
| 2025-08-14 4:43 pm Purchase | 2025-06-30 | 13G | Grace Therapeutics, Inc. GRCE | Nantahala Capital Management, LLC | 1,404,032 9.990% | 12,259![]() (+0.88%) | Filing History |
| 2025-08-14 4:43 pm Purchase | 2025-06-30 | 13G | Fossil Group, Inc. FOSL | Nantahala Capital Management, LLC | 5,087,803 9.490% | 898,626![]() (+21.45%) | Filing History |
| 2025-08-14 4:42 pm Unchanged | 2025-06-30 | 13G | Eagle Pharmaceuticals, Inc. EGRX | Nantahala Capital Management, LLC | 4,945,209 38.080% | 0 (Unchanged) | Filing History |
| 2025-08-14 4:41 pm Purchase | 2025-06-30 | 13G | DarioHealth Corp. DRIO | Nantahala Capital Management, LLC | 234,501 9.990% | 58,854![]() (+33.51%) | Filing History |
| 2025-08-14 4:40 pm Purchase | 2025-06-30 | 13G | COMPASS Pathways plc CMPS | Nantahala Capital Management, LLC | 5,934,315 6.230% | 5,934,315![]() (New Position) | Filing History |
| 2025-08-14 4:39 pm Purchase | 2025-06-30 | 13G | Cellectar Biosciences, Inc. CLRB | Nantahala Capital Management, LLC | 1,109 0.060% | 1,109![]() (New Position) | Filing History |
| 2025-08-14 4:38 pm Sale | 2025-06-30 | 13G | uniQure N.V. QURE | Nantahala Capital Management, LLC | 2,051,852 3.750% | -930,161![]() (-31.19%) | Filing History |
| 2025-08-14 4:38 pm Purchase | 2025-06-30 | 13G | Unicycive Therapeutics, Inc. UNCY | Nantahala Capital Management, LLC | 1,234,596 9.990% | 10,257![]() (+0.84%) | Filing History |

